III BRAZILIAN CONSENSUS STATEMENT ON ENDOSCOPIC ULTRASOUND
Ricardo Rangel de Paula Pessoa,Alexandre Moraes Bestetti,Victor Lira de Oliveira,Wladimir Campos de Araujo,Simone Guaraldi,Rodrigo Roda Rodrigues Silva,Francisco Antonio Araujo Oliveira,Maria Sylvia Ierardi Ribeiro,Fred Olavo Aragão Andrade Carneiro,Marco Aurélio D'Assunção,Bruno Frederico Oliveira Azevedo Medrado,Felipe Alves Retes,Gustavo Andrade de Paulo,Nutianne Camargo Schneider,Lucio Giovanni Battista Rossini,Leonardo Vallinoto,Jose Celso Ardengh,Djalma Ernesto Coelho Neto,Edson Ide,Marcos Clarencio Batista Silva,Matheus Cavalcante Franco,Sergio Eiji Matuguma,Diogo Turiani Hourneaux de Moura,Vitor Nunes Arantes,Rafael Nahoum,Vitor Ottoboni Brunaldi,Marcos Eduardo Lera Dos Santos,Dalton Marques Chaves,Otávio Micelli-Neto,Bruno Chaves Salomao,Fauze Maluf-Filho,Gustavo de Oliveira Luz
DOI: https://doi.org/10.1590/S0004-2803.24612024-062
2024-10-21
Abstract:Background: In the past decades, endoscopic ultrasound has developed from a diagnostic tool to a platform for many therapeutic interventions. Various technological advancements have emerged since the last Brazilian Consensus, demanding a review and update of the recommendations based on the best scientific evidence. Methods: A group of 32 renowned echoendoscopists selected eight relevant topics to be discussed to generate clinical questions. After that, a literature review was conducted to answer these questions based on the most updated evidence. Results: Thirty-three statements were formulated and voted on by the experts to reach a consensus. The Oxford System was used to grade the level of evidence. Conclusion: There is mo-derate evidence to support that the needle shape, gauge, or aspiration technique does not influence the yield of endoscopic ultrasound (EUS)-guided tissue sampling of pancreatic solid lesions. There is moderate evidence to support using EUS-TTNB of the cyst wall to differentiate between mucinous and non-mucinous cystic neoplasms. There is little evidence to support the EUS-guided treatment of gastric varices. There is a high level of evidence to support that EUS-guided biliary drainage and ERCP present similar outcomes in patients with distal malignant biliary obstruction. There is a high level of evidence for using EUS to diagnose neoplastic pancreatic cysts and detect necrosis before indicating drainage. There is moderate evidence to support EUS-GE over duodenal stent for malignant gastric outlet obstruction in patients with a life expectancy higher than 2 months. There is a high level of evidence to support the use of RFA in treating both functioning and non-functioning types of NET.